|
Post by falconquest on Jun 11, 2018 5:52:32 GMT -5
How about we give this woman a chance. If Mike is fine with her, I'm good with it. And we say it all the time, if money situation is so dire..and we only have a few months of cash left, you don’t hire executives at this point..nor do highly respected execs leave large BP to come to a dying company... .....and you're right, we say it all the time. Additionally, I seem to recall the last time speculation ran rampant after a hire that Amgen was interested in Mannkind, now it's Dexcom.........again!
|
|
|
Post by hellodolly on Jun 11, 2018 6:39:41 GMT -5
How about we give this woman a chance. If Mike is fine with her, I'm good with it. And we say it all the time, if money situation is so dire..and we only have a few months of cash left, you don’t hire executives at this point..nor do highly respected execs leave large BP to come to a dying company... Which begets the remaining thoughts we know are laid out on the table:
We have the ADA upcoming, we have 'veins of gold', we have a new SAB, we have a new shelf registration in place, we have international deals inked, we have studies, we have TrepT...so leave your jobs, leave your comfort zone, risk your reputation and join MNKD!
Kendall - I'm in... Garrett - I'm in...
Who or what else remains a piece of the "New MNKD" and/or who else gets booted to make room for the "New MNKD"?
|
|
|
Post by morgieporgie on Aug 6, 2018 22:56:04 GMT -5
P.S. My father is setting up his appointment with VDEX in Espanola next week and I have not heard him as enthused about anything relating to his disease since. How did your dads vdex appointment go? If I may ask..
|
|